Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)
暂无分享,去创建一个
P. Rougier | A. Zubel | M. Peeters | J. Raoul | C. Brézault | J. V. Laethem | L. Cals | F. Husseini | J. Vedovato | J. Laethem